CVS Stock Rises Ahead Of Lost Tobacco Sales

  • Playlist
  • Download
  • Embed
    Embed <iframe src="http://www.npr.org/player/embed/275796856/275796857" width="100%" height="290" frameborder="0" scrolling="no">
  • Transcript

Less than a week after CVS announced it would no longer sell tobacco products, its stock is on the rise.

STEVE INSKEEP, HOST:

Less than a week after CVS announced its decision to stop selling tobacco products, the company's stock is on the rise. Share prices were up 2.3 percent yesterday, after posting higher-than-expected quarterly profits.

RENEE MONTAGNE, HOST:

CVS reports it processed more prescriptions and benefited from the introduction of new generic drugs last quarter. Company executives say they hope these sales trends offset a predicted drop in revenue. The ubiquitous pharmacy chain projects it will lose $1.5 billion every year from not selling cigarettes.

Copyright © 2014 NPR. All rights reserved. Visit our website terms of use and permissions pages at www.npr.org for further information.

NPR transcripts are created on a rush deadline by a contractor for NPR, and accuracy and availability may vary. This text may not be in its final form and may be updated or revised in the future. Please be aware that the authoritative record of NPR’s programming is the audio.

Comments

 

Please keep your community civil. All comments must follow the NPR.org Community rules and terms of use, and will be moderated prior to posting. NPR reserves the right to use the comments we receive, in whole or in part, and to use the commenter's name and location, in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.